Supruniuk Elżbieta, Grubczak Kamil, Parfieniuk-Kowerda Anna, Flisiak Robert, Moniuszko Marcin, Jaroszewicz Jerzy, Chabowski Adrian, Świderska Magdalena
Department of Physiology, Medical University of Bialystok, Bialystok, Poland.
Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.
Front Immunol. 2025 Aug 22;16:1597204. doi: 10.3389/fimmu.2025.1597204. eCollection 2025.
Dysregulation of immune responses may influence the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) to metabolic dysfunction-associated steatohepatitis (MASH). Our recent data suggest the role of Th17-related cytokines in fibrosis advancement in MASLD. Herein, we aimed to analyze T-regulatory and Th17-producing T-lymphocytes by flow cytometry with respect to MASLD progression.
Extensive immunophenotyping was performed in a subset of 30 patients with MASLD diagnosed by elastography and ultrasonography and 15 healthy controls (HCs). Ex-vivo surface markers (CD4, CD25, CD127) and intracellular cytokine expressions (IL-10, IL-17, Foxp3, RORgt) were analyzed by flow cytometry (BD FACS-Calibur). Plasma concentrations of selected interleukins such as IL-10, IL22, and IL-17A were measured by ELISA.
19/30 (63%) of MASLD patients were diagnosed with steatosis with inflammation (advanced MASLD) as compared to simple steatosis (early MASLD) using elastography. The percentage of IL-17-producing cells among CD4(+) T-lymphocytes was two-fold more frequent (1.70% . 0.73%), while of T-regulatory cells (CD4+CD25+Foxp3+, T-regs) lower (3.57% . 6.56%) in advanced MASLD compared to HCs. This resulted in an aberrated ratio of Th17 to Tregs in MASLD (p=0.004). The frequency of T-regulatory cells (CD4+CD25+Foxp3+, Tregs) declined also in the advanced MASLD patients (3.57%) compared to the early stage disease (5.16%). Importantly, IL-10 and IL-17A serum levels positively correlated with CD4+IL-17+/CD4+CD25+Foxp3+ ratio. Plasma IL-10/IL-17A ratio and IL-10/IL-22 ratio significantly differed between F0 fibrosis . moderate (F2).
The imbalance between Th17 and T-regulatory immune responses is present not only at cytokine level but also at a cellular level in MASLD. Especially in advanced disease, a higher percentage of IL-17 producing T-cells is coupled with the lower number of T-regulatory cells.
免疫反应失调可能会影响代谢功能障碍相关脂肪性肝病(MASLD)向代谢功能障碍相关脂肪性肝炎(MASH)的进展。我们最近的数据表明Th17相关细胞因子在MASLD纤维化进展中发挥作用。在此,我们旨在通过流式细胞术分析调节性T细胞和产生Th17的T淋巴细胞与MASLD进展的关系。
对30例经弹性成像和超声检查诊断为MASLD的患者及15名健康对照(HC)进行广泛的免疫表型分析。通过流式细胞术(BD FACS-Calibur)分析体外表面标志物(CD4、CD25、CD127)和细胞内细胞因子表达(IL-10、IL-17、Foxp3、RORγt)。采用ELISA法检测血浆中IL-10、IL22和IL-17A等选定白细胞介素的浓度。
与单纯脂肪变性(早期MASLD)相比,使用弹性成像诊断为脂肪变性伴炎症(晚期MASLD)的MASLD患者有19/30(63%)。与HC相比,晚期MASLD患者中CD4(+) T淋巴细胞中产生IL-17的细胞百分比高出两倍(1.70% . 0.73%),而调节性T细胞(CD4+CD25+Foxp3+,Tregs)的百分比更低(3.57% . 6.56%)。这导致MASLD中Th17与Tregs的比例异常(p=0.004)。与疾病早期(5.16%)相比,晚期MASLD患者中调节性T细胞(CD4+CD25+Foxp3+,Tregs)的频率也有所下降(3.57%)。重要的是,IL-10和IL-17A血清水平与CD4+IL-17+/CD4+CD25+Foxp3+比值呈正相关。F0纤维化.中度(F2)之间血浆IL-10/IL-17A比值和IL-10/IL-22比值有显著差异。
Th17和调节性免疫反应之间的失衡不仅存在于细胞因子水平,也存在于MASLD的细胞水平。特别是在晚期疾病中,产生IL-17的T细胞百分比更高,而调节性T细胞数量更低。